Cleared Traditional

K040073 - SYSMEX AUTOMATED HEMATOLOGY ANALYZER

K040073 is the FDA 510(k) clearance for SYSMEX AUTOMATED HEMATOLOGY ANALYZER by Sysmex America, Inc.. It is a Class 2 Hematology device (product code GKZ) cleared through the Traditional 510(k) pathway after a 64-day FDA review.

K040073 · Sysmex America, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2004
Decision
64d
Days
Class 2
Risk

K040073 is an FDA 510(k) clearance for the SYSMEX AUTOMATED HEMATOLOGY ANALYZER, XE-2100 SERIES (XE-2100, XE-2100L). Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Sysmex America, Inc. (Mundelein, US). The FDA issued a Cleared decision on March 18, 2004 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sysmex America, Inc. devices

Submission Details

510(k) Number K040073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 14, 2004
Decision Date March 18, 2004
Days to Decision 64 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 113d · This submission: 64d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 194
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K040073.
MODIFICATION TO COULTER LH 500 HEMATOLOGY ANALYZER
K042724 · Beckman Coulter, Inc. · Oct 2004
COULTER A T 5DIFF CAP PIERCE (CP)
K042173 · Beckman Coulter, Inc. · Oct 2004
BAYER ADVIA 2120 HEMATOLOGY ANALYZER WITH AUTOSLIDE SYSTEM
K042251 · Bayer Healthcare, LLC · Sep 2004
COULTER LH 750 HEMATOLOGY ANALYZER
K032342 · Beckman Coulter, Inc. · Sep 2003
ADVIA 60 HEMATOLOGY ANALYZER
K032524 · Bayer Healthcare, LLC · Sep 2003
COULTER LH 500 HEMATOLOGY ANALYZER
K032000 · Beckman Coulter, Inc. · Aug 2003